LEX Diagnostics News and Activities

LEX Diagnostics is owned by QuidelOrtho.

QuidelOrtho is one of the...

• Fortune 500 (#890);
• Russell 3000;
• TOB Iconic 10,000.

QuidelOrtho is a company listed under the stock ticker QDEL (US).

QuidelOrtho has a direct presence in 4 countries.

QuidelOrtho has 3 subsidiaries including LEX Diagnostics, QuidelOrtho APAC and QuidelOrtho EMEA.

They are in:

• Medical Equipment75%
• Biotechnology25%

Acquisition, funding and merger involving QuidelOrtho.

• QuidelOrtho has acquired LEX Diagnostics (posted on April 22 2026).
• QuidelOrtho has acquired LEX Diagnostics (posted on April 20 2026).

View the org chart displaying its 9 main executives

Most searched biographies at LEX Diagnostics

• Ed Farrell, Chief Executive Officer
• Heather Danks, Chief Technology Officer
• Chris Hole, Vice President, Commercial

Popular executive movements at QuidelOrtho

• Nathaniel Sisitsky has joined the company as Chief Legal Officer  (posted on March 24 2026).

Create your alert
to follow the executive moves at LEX Diagnostics.

QuidelOrtho has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by LEX Diagnostics

• Contact – LEX Diagnostics
• Press releases – LEX Diagnostics
• In the News – LEX Diagnostics

Social media about LEX Diagnostics

• LEX Diagnostics on Wikipedia, Google News & Yahoo Finance
• LEX Diagnostics on LinkedIn, X (Twitter) & YouTube